Sales & Marketing News | pharmaphorum

News

Actemra shortage spills over to include Sanofi's rival Kevza...

Roche's Actemra has been in high demand since its value in treating severe COVID-19 was established, leading to shortages.

News

Close-up image of a firm handshake between two colleagues

Supernus bulks up its Parkinson's portfolio with Adamas take...

Supernus has boosted its position in central nervous system therapies with a $400 million deal to acquire Adamas Pharma that will add two approved Parkinson's disease therapies to its stabl

News

Oxford Nanopore makes stellar debut on UK stock market

Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Exchange yesterday, rising nearly 50% to propel its valuation up towards th

News

Merck confirms $11.5bn Acceleron takeover deal

After days of speculation, Merck & Co confirmed today that it has agreed to acquire Acceleron Pharma $1.5 billion, setting up what could be one of the largest biopharma acquisitions of

News

Rumour mill says Acceleron is speeding towards $11bn sale

US biopharma company Acceleron is the next company heading for a takeover by a big pharma group – according to a Bloomberg report citing people close to the matter.

News

Second hedge fund applies pressure on GSK after taking stake

Activist hedge fund Bluebell Capital Partners has joined Elliott Investment in taking a stake in GlaxoSmithKline and pushing for change at the pharma company.

Actemra shortage spills over to include Sanofi's rival Kevza...

Supernus bulks up its Parkinson's portfolio with Adamas take...

Oxford Nanopore makes stellar debut on UK stock market

Merck confirms $11.5bn Acceleron takeover deal

Rumour mill says Acceleron is speeding towards $11bn sale

Second hedge fund applies pressure on GSK after taking stake

UK offers meningitis jab to young people after outbreak

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks